ArticleScientific reports2026
Association between the blood urea nitrogen to albumin ratio and 30-day mortality in critically ill children with acute kidney injury.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury (AKI) is common in the pediatric intensive care unit (PICU). The blood urea nitrogen to albumin ratio (BAR) is an emerging prognostic marker for critically ill patients. However, its association with outcomes in critically ill children with AKI remains unclear. Pediatric patients with AKI and available BAR measurements were identified from the Pediatric Intensive Care (PIC) database. The primary outcome was 30-day all cause mortality. Multivariate Cox regression analysis was used to clarify the relationship between BAR and the primary outcome. Receiver operating characteristic (ROC) curve analysis was performed to compare the predictive ability of BAR against its components and a referenced biomarker. Kaplan-Meier survival analysis, restricted cubic splines, and stratified analysis were used to verify the findings. The study included 1778 pediatric AKI patients. A significant positive association was observed between BAR and 30-day mortality (HR 1.15, 95% CI 1.05–1.25, p < 0.01). Further analysis revealed a significant non-linear relationship, with an identified inflection point at BAR = 2.49. Based on the optimal cutoff value of 4.07 identified by ROC curve analysis, patients were stratified into a high BAR group and a low BAR group. After multivariate adjustment, the high BAR group showed significantly increased mortality compared to the low BAR group (HR 1.87, 95% CI 1.24–2.84, p < 0.01), a finding that was further supported by a significant separation in Kaplan-Meier survival curves. Subgroup analyses confirmed the robustness of this association across sex, age, and comorbidity subgroups. An elevated BAR was independently associated with short-term mortality in critically ill children with AKI. As a readily available biomarker, BAR may hold potential for risk stratification. Nevertheless, its clinical utility necessitates further validation in prospective studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.